Publication Cover
Synthetic Communications
An International Journal for Rapid Communication of Synthetic Organic Chemistry
Volume 39, 2009 - Issue 12
258
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

Convenient One-Pot Synthesis of 3,4-Dihydropyrimidin-2(1H)-ones Using TMSCl as a Catalyst with Ultrasonic Irradiation in DMF

&
Pages 2205-2220 | Received 17 Jul 2008, Published online: 13 May 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Yan-Qin Yuan & Sheng-Rong Guo. (2011) TMSCl/Fe(NO3)3-Catalyzed Synthesis of 2-Arylbenzothiazoles and 2-Arylbenzimidazoles Under Ultrasonic Irradiation. Synthetic Communications 41:14, pages 2169-2177.
Read now

Articles from other publishers (4)

Waquar Ahsan. 2023. Dihydropyrimidinones as Potent Anticancer Agents. Dihydropyrimidinones as Potent Anticancer Agents 17 38 .
Susmita Saikia & Ruli Borah. (2019) One‐Pot Sequential Synthesis of 2‐Amino‐4, 6‐Diaryl Pyrimidines Involving SO 3 H‐Functionalized Piperazinium‐Based Dicationic Ionic Liquids as Homogeneous Catalysts . ChemistrySelect 4:30, pages 8751-8756.
Crossref
Kawaljit Singh & Kamaljit Singh. 2012. 223 308 .
Sheng‐rong Guo & Yan‐qin Yuan. (2009) ChemInform Abstract: Convenient One‐Pot Synthesis of 3,4‐Dihydropyrimidin‐2(1H)‐ones Using TMSCl as a Catalyst with Ultrasonic Irradiation in DMF.. ChemInform 40:44.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.